Autologous Matrix-Induced Chondrogenesis (AMIC) Report 2021 - Global Market Trajectory & Analytics 2012-2019 & 2020-2027 - ResearchAndMarkets.com

The "Autologous Matrix-Induced Chondrogenesis (AMIC) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, May 25, 2021
Information
Tags: 
General Health, Health, Stem cells, Medical specialties, Alcohols, Medicine, AMIC, Autologous matrix-induced chondrogenesis, Polyethers, Polyethylene glycol, Compound annual growth rate, Ethylene glycol
Geotags: 
JAPAN, US, EUROPE, CHINA, INDIA, SOUTH KOREA, USA, AUSTRALIA, CANADA, GERMANY
Summary
Key Points: 
  • The "Autologous Matrix-Induced Chondrogenesis (AMIC) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Hyaluronic Acid, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$50.8 Million by the end of the analysis period.
  • In the global Polyethylene Glycol (PEG) segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$22.3 Million by the year 2027.


The "Autologous Matrix-Induced Chondrogenesis (AMIC) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market to Reach $193.2 Million by 2027

Amid the COVID-19 crisis, the global market for Autologous Matrix-Induced Chondrogenesis (AMIC), estimated at US$118.6 Million in the year 2020, is projected to reach a revised size of US$193.2 Million by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027.

Hyaluronic Acid, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$50.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Collagen segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $35.1 Million, While China is Forecast to Grow at 6.7% CAGR

The Autologous Matrix-Induced Chondrogenesis (AMIC) market in the U.S. is estimated at US$35.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$33.7 Million by the year 2027 trailing a CAGR of 6.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Polyethylene Glycol (PEG) Segment to Record 9.7% CAGR

In the global Polyethylene Glycol (PEG) segment, USA, Canada, Japan, China and Europe will drive the 9.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12.1 Million in the year 2020 will reach a projected size of US$23.2 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$22.3 Million by the year 2027.

Select Competitors (Total 41 Featured):

  • Anika Therapeutics, Inc.
  • Arthro Kinetics AG
  • B. Braun Melsungen AG
  • BioTissue SA
  • CartiHeal, Inc.
  • Geistlich Pharma AG
  • JRI Orthopaedics Ltd.
  • Matricel GmbH
  • Smith & Nephew PLC
  • Zimmer Biomet Holdings, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • World 15-Year Perspective for Autologous Matrix-Induced Chondrogenesis (AMIC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Hyaluronic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Collagen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Polyethylene Glycol (PEG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Polylactic-Co-Glycolic Acid (PGLA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • World 15-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/2dvwp0

Copyright: 
Copyright Business Wire 2021